Cargando…
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being di...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740061/ https://www.ncbi.nlm.nih.gov/pubmed/29269835 http://dx.doi.org/10.1038/s41467-017-02098-8 |
_version_ | 1783287971471949824 |
---|---|
author | Crook, Zachary R. Sevilla, Gregory P. Friend, Della Brusniak, Mi-Youn Bandaranayake, Ashok D. Clarke, Midori Gewe, Mesfin Mhyre, Andrew J. Baker, David Strong, Roland K. Bradley, Philip Olson, James M. |
author_facet | Crook, Zachary R. Sevilla, Gregory P. Friend, Della Brusniak, Mi-Youn Bandaranayake, Ashok D. Clarke, Midori Gewe, Mesfin Mhyre, Andrew J. Baker, David Strong, Roland K. Bradley, Philip Olson, James M. |
author_sort | Crook, Zachary R. |
collection | PubMed |
description | Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being difficult to produce, owing to their complex disulfide connectivity. Here we describe a platform for identifying target-binding cystine-dense peptides using mammalian surface display, capable of interrogating high quality and diverse scaffold libraries with verifiable folding and stability. We demonstrate the platform’s capabilities by identifying a cystine-dense peptide capable of inhibiting the YAP:TEAD interaction at the heart of the oncogenic Hippo pathway, and possessing the potency and stability necessary for consideration as a drug development candidate. This platform provides the opportunity to screen cystine-dense peptides with drug-like qualities against targets that are implicated for the treatment of diseases, but are poorly suited for conventional approaches. |
format | Online Article Text |
id | pubmed-5740061 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-57400612017-12-26 Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets Crook, Zachary R. Sevilla, Gregory P. Friend, Della Brusniak, Mi-Youn Bandaranayake, Ashok D. Clarke, Midori Gewe, Mesfin Mhyre, Andrew J. Baker, David Strong, Roland K. Bradley, Philip Olson, James M. Nat Commun Article Protein:protein interactions are among the most difficult to treat molecular mechanisms of disease pathology. Cystine-dense peptides have the potential to disrupt such interactions, and are used in drug-like roles by every clade of life, but their study has been hampered by a reputation for being difficult to produce, owing to their complex disulfide connectivity. Here we describe a platform for identifying target-binding cystine-dense peptides using mammalian surface display, capable of interrogating high quality and diverse scaffold libraries with verifiable folding and stability. We demonstrate the platform’s capabilities by identifying a cystine-dense peptide capable of inhibiting the YAP:TEAD interaction at the heart of the oncogenic Hippo pathway, and possessing the potency and stability necessary for consideration as a drug development candidate. This platform provides the opportunity to screen cystine-dense peptides with drug-like qualities against targets that are implicated for the treatment of diseases, but are poorly suited for conventional approaches. Nature Publishing Group UK 2017-12-21 /pmc/articles/PMC5740061/ /pubmed/29269835 http://dx.doi.org/10.1038/s41467-017-02098-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Crook, Zachary R. Sevilla, Gregory P. Friend, Della Brusniak, Mi-Youn Bandaranayake, Ashok D. Clarke, Midori Gewe, Mesfin Mhyre, Andrew J. Baker, David Strong, Roland K. Bradley, Philip Olson, James M. Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title_full | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title_fullStr | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title_full_unstemmed | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title_short | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
title_sort | mammalian display screening of diverse cystine-dense peptides for difficult to drug targets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740061/ https://www.ncbi.nlm.nih.gov/pubmed/29269835 http://dx.doi.org/10.1038/s41467-017-02098-8 |
work_keys_str_mv | AT crookzacharyr mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT sevillagregoryp mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT frienddella mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT brusniakmiyoun mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT bandaranayakeashokd mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT clarkemidori mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT gewemesfin mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT mhyreandrewj mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT bakerdavid mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT strongrolandk mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT bradleyphilip mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets AT olsonjamesm mammaliandisplayscreeningofdiversecystinedensepeptidesfordifficulttodrugtargets |